Charles Vauchier

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Nadia Guezour, Ghassen Soussi, Solenn Brosseau, Baptiste Abbar, Charles Naltet, Charles Vauchier, Nicolas Poté, Lorry Hachon, Céline Namour, Antoine Khalil, Jean Trédaniel, Gérard Zalcman, Valérie Gounant
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study. Cancers 14 (16) (2022)
Charles Vauchier, Edouard Auclin, Philippe Barthélémy, Lucia Carril-Ajuria, Thomas Ryckewaert, Delphine Borchiellini, Zahra Castel-Ajgal, Mostefa Bennamoun, Luca Campedel, Antoine Thiery-Vuillemin, Elodie Coquan, Laurence Crouzet, Jean-François Berdah, Christine Chevreau, Raffaele Ratta, Aude Fléchon, Felix Lefort, Laurence Albiges, Marine Gross-Goupil, Yann-Alexandre Vano, Constance Thibault, Stephane Marie Oudard
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study. Journal of oncology 2022 (2022)

Charles Vauchier.css-eqlu8i{font-size:small;padding-left:4px;}